Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft Rejection | 45 | 2022 | 4397 | 3.550 |
Why?
|
Transplantation Tolerance | 16 | 2022 | 617 | 3.200 |
Why?
|
Isoantigens | 16 | 2022 | 567 | 2.720 |
Why?
|
Transplantation, Homologous | 46 | 2022 | 4776 | 2.150 |
Why?
|
Skin Transplantation | 19 | 2020 | 1074 | 2.080 |
Why?
|
T-Lymphocytes | 41 | 2022 | 10180 | 1.830 |
Why?
|
Immune Tolerance | 25 | 2022 | 2258 | 1.540 |
Why?
|
Chimerism | 9 | 2022 | 158 | 1.490 |
Why?
|
Exosomes | 3 | 2021 | 417 | 1.460 |
Why?
|
Immunologic Memory | 11 | 2020 | 1348 | 1.210 |
Why?
|
Antigen Presentation | 13 | 2020 | 1284 | 1.210 |
Why?
|
Graft Survival | 20 | 2018 | 3737 | 1.110 |
Why?
|
Histocompatibility Antigens | 9 | 2022 | 471 | 1.010 |
Why?
|
Kidney Transplantation | 14 | 2022 | 4251 | 0.990 |
Why?
|
Heart Transplantation | 17 | 2018 | 3110 | 0.970 |
Why?
|
Bone Marrow Transplantation | 14 | 2015 | 2765 | 0.970 |
Why?
|
Major Histocompatibility Complex | 13 | 2015 | 936 | 0.900 |
Why?
|
Corneal Transplantation | 7 | 2013 | 386 | 0.880 |
Why?
|
Histocompatibility Antigens Class II | 12 | 2010 | 1475 | 0.880 |
Why?
|
Antigen-Presenting Cells | 8 | 2021 | 973 | 0.870 |
Why?
|
Interleukin-2 | 13 | 2016 | 1904 | 0.860 |
Why?
|
Mice, Inbred BALB C | 30 | 2020 | 6386 | 0.810 |
Why?
|
Autoantigens | 11 | 2018 | 892 | 0.750 |
Why?
|
CD8-Positive T-Lymphocytes | 13 | 2020 | 4479 | 0.690 |
Why?
|
Histocompatibility Antigens Class I | 12 | 2009 | 1366 | 0.680 |
Why?
|
Lymphocyte Depletion | 4 | 2015 | 608 | 0.670 |
Why?
|
Macaca fascicularis | 13 | 2015 | 915 | 0.640 |
Why?
|
CD4-Positive T-Lymphocytes | 17 | 2020 | 4386 | 0.640 |
Why?
|
Transplantation Immunology | 3 | 2011 | 546 | 0.600 |
Why?
|
H-2 Antigens | 4 | 2010 | 366 | 0.590 |
Why?
|
Transplantation Chimera | 6 | 2015 | 612 | 0.580 |
Why?
|
Lymphocyte Activation | 19 | 2013 | 5524 | 0.570 |
Why?
|
Isoantibodies | 4 | 2015 | 679 | 0.550 |
Why?
|
Animals | 93 | 2022 | 168757 | 0.520 |
Why?
|
Antigens, CD20 | 1 | 2015 | 199 | 0.500 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2016 | 272 | 0.490 |
Why?
|
Transplantation Conditioning | 10 | 2016 | 1598 | 0.480 |
Why?
|
Dendritic Cells | 5 | 2013 | 2725 | 0.480 |
Why?
|
Receptors, Antigen, T-Cell | 7 | 2010 | 2540 | 0.460 |
Why?
|
Self Tolerance | 5 | 2006 | 125 | 0.460 |
Why?
|
Peptides | 12 | 2001 | 4409 | 0.450 |
Why?
|
Interferon-gamma | 17 | 2016 | 3206 | 0.450 |
Why?
|
Lymphoid Tissue | 1 | 2014 | 455 | 0.450 |
Why?
|
Mice | 59 | 2021 | 81183 | 0.450 |
Why?
|
T-Lymphocyte Subsets | 9 | 2014 | 1838 | 0.440 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 430 | 0.420 |
Why?
|
Free Radical Scavengers | 2 | 2006 | 216 | 0.400 |
Why?
|
Th1 Cells | 9 | 2009 | 1057 | 0.400 |
Why?
|
Autoimmunity | 8 | 2009 | 1349 | 0.390 |
Why?
|
Th2 Cells | 9 | 2009 | 1061 | 0.390 |
Why?
|
Myosins | 3 | 2002 | 409 | 0.390 |
Why?
|
Transplants | 1 | 2013 | 209 | 0.380 |
Why?
|
Tissue Donors | 3 | 2018 | 2240 | 0.360 |
Why?
|
Mice, Inbred C57BL | 26 | 2020 | 21827 | 0.350 |
Why?
|
Immunomodulation | 1 | 2013 | 541 | 0.330 |
Why?
|
B-Lymphocytes | 4 | 2020 | 4665 | 0.330 |
Why?
|
CD40 Ligand | 7 | 2013 | 526 | 0.310 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2000 | 880 | 0.300 |
Why?
|
Cardiac Myosins | 3 | 2018 | 117 | 0.300 |
Why?
|
Mice, Inbred CBA | 5 | 2010 | 448 | 0.300 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2015 | 2988 | 0.290 |
Why?
|
Maternal-Fetal Exchange | 3 | 2020 | 456 | 0.280 |
Why?
|
Organ Transplantation | 1 | 2016 | 1139 | 0.270 |
Why?
|
Killer Cells, Natural | 2 | 2012 | 2133 | 0.260 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5442 | 0.260 |
Why?
|
Antibodies, Monoclonal | 8 | 2015 | 9274 | 0.260 |
Why?
|
Epitopes | 8 | 2002 | 2571 | 0.250 |
Why?
|
Mice, Inbred C3H | 3 | 2015 | 964 | 0.250 |
Why?
|
Manganese | 1 | 2006 | 408 | 0.230 |
Why?
|
Bone Marrow Cells | 3 | 2013 | 2513 | 0.230 |
Why?
|
Adaptation, Physiological | 2 | 2007 | 1312 | 0.230 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2538 | 0.210 |
Why?
|
Diphtheria Toxin | 2 | 2014 | 255 | 0.210 |
Why?
|
Peptide Fragments | 9 | 2003 | 5097 | 0.210 |
Why?
|
HLA Antigens | 2 | 1998 | 1381 | 0.200 |
Why?
|
Adaptive Immunity | 2 | 2020 | 713 | 0.190 |
Why?
|
Luminescent Measurements | 6 | 1991 | 405 | 0.190 |
Why?
|
Sarcoma, Experimental | 1 | 2000 | 128 | 0.180 |
Why?
|
Skin | 1 | 2013 | 4364 | 0.180 |
Why?
|
Mice, Transgenic | 5 | 2015 | 9734 | 0.170 |
Why?
|
Amino Acid Sequence | 11 | 2014 | 13815 | 0.170 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2077 | 0.160 |
Why?
|
Immunosuppressive Agents | 6 | 2015 | 4149 | 0.160 |
Why?
|
Molecular Sequence Data | 12 | 2014 | 18111 | 0.160 |
Why?
|
Autoimmune Diseases | 4 | 2010 | 2133 | 0.160 |
Why?
|
Swine, Miniature | 3 | 2016 | 961 | 0.160 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2006 | 2948 | 0.150 |
Why?
|
Alopecia Areata | 1 | 1999 | 107 | 0.150 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2014 | 310 | 0.150 |
Why?
|
Ethylenediamines | 1 | 1997 | 48 | 0.150 |
Why?
|
Vimentin | 1 | 2018 | 261 | 0.150 |
Why?
|
Interleukin-4 | 3 | 2011 | 1147 | 0.150 |
Why?
|
Lung Transplantation | 2 | 2015 | 1153 | 0.140 |
Why?
|
Models, Immunological | 2 | 2010 | 527 | 0.140 |
Why?
|
Kidney Function Tests | 2 | 2015 | 684 | 0.140 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2013 | 59 | 0.130 |
Why?
|
Biological Factors | 1 | 1995 | 164 | 0.120 |
Why?
|
Interleukin-15 | 2 | 2012 | 184 | 0.120 |
Why?
|
Papio | 1 | 2016 | 656 | 0.120 |
Why?
|
Antibodies, Neoplasm | 2 | 2006 | 286 | 0.120 |
Why?
|
Macrophage Activation | 2 | 1988 | 558 | 0.120 |
Why?
|
Lymphocyte Transfusion | 1 | 2015 | 236 | 0.120 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 666 | 0.120 |
Why?
|
Organ Specificity | 2 | 2013 | 2008 | 0.120 |
Why?
|
Myocardium | 3 | 2012 | 4776 | 0.120 |
Why?
|
Swine | 4 | 2022 | 5917 | 0.120 |
Why?
|
Receptors, Fc | 2 | 1987 | 541 | 0.110 |
Why?
|
Adolescent Psychiatry | 1 | 1995 | 148 | 0.110 |
Why?
|
Postoperative Complications | 2 | 2015 | 15295 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2020 | 2958 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 226 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 1997 | 665 | 0.110 |
Why?
|
Mice, Inbred Strains | 6 | 2003 | 1827 | 0.110 |
Why?
|
Transplantation, Isogeneic | 3 | 2002 | 257 | 0.110 |
Why?
|
Psychophysiologic Disorders | 1 | 1995 | 228 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2009 | 3870 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 4 | 2014 | 3772 | 0.110 |
Why?
|
Mice, Inbred A | 4 | 2004 | 248 | 0.110 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2015 | 745 | 0.110 |
Why?
|
Immunoconjugates | 2 | 2014 | 901 | 0.100 |
Why?
|
Immunotoxins | 1 | 2012 | 179 | 0.100 |
Why?
|
Radiation Chimera | 1 | 2011 | 223 | 0.100 |
Why?
|
Myocarditis | 1 | 1999 | 771 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1997 | 835 | 0.100 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2011 | 57 | 0.100 |
Why?
|
School Health Services | 1 | 1995 | 375 | 0.100 |
Why?
|
Injections, Intraperitoneal | 3 | 2001 | 425 | 0.100 |
Why?
|
Thymus Gland | 3 | 2010 | 1267 | 0.100 |
Why?
|
Maleimides | 1 | 2011 | 112 | 0.100 |
Why?
|
Zymosan | 2 | 1988 | 124 | 0.090 |
Why?
|
Retina | 1 | 2001 | 2616 | 0.090 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2012 | 279 | 0.090 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 987 | 0.090 |
Why?
|
Mice, Knockout | 5 | 2014 | 14557 | 0.090 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2012 | 314 | 0.090 |
Why?
|
Flow Cytometry | 4 | 2014 | 5974 | 0.090 |
Why?
|
Adoptive Transfer | 2 | 2009 | 844 | 0.090 |
Why?
|
beta Catenin | 2 | 2011 | 1059 | 0.080 |
Why?
|
Intracellular Space | 1 | 2010 | 212 | 0.080 |
Why?
|
Transduction, Genetic | 2 | 2010 | 913 | 0.080 |
Why?
|
Immunoglobulin G | 5 | 2003 | 4560 | 0.080 |
Why?
|
Cells, Cultured | 6 | 2011 | 19229 | 0.080 |
Why?
|
Proteins | 2 | 2022 | 6103 | 0.080 |
Why?
|
Chronic Disease | 5 | 2011 | 9146 | 0.080 |
Why?
|
Pulmonary Alveoli | 2 | 1988 | 675 | 0.080 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 2382 | 0.080 |
Why?
|
Coculture Techniques | 1 | 2011 | 1341 | 0.080 |
Why?
|
Models, Animal | 3 | 2015 | 2171 | 0.080 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 903 | 0.080 |
Why?
|
Cytokines | 4 | 2009 | 7322 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2170 | 0.080 |
Why?
|
Crosses, Genetic | 3 | 2003 | 791 | 0.080 |
Why?
|
Immunotherapy | 3 | 1999 | 4445 | 0.070 |
Why?
|
Serine | 1 | 2011 | 826 | 0.070 |
Why?
|
Retroviridae | 1 | 2010 | 914 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1801 | 0.070 |
Why?
|
Hepatovirus | 2 | 1997 | 50 | 0.070 |
Why?
|
Female | 20 | 2020 | 380194 | 0.070 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 1613 | 0.070 |
Why?
|
Immunization | 3 | 2011 | 1256 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1866 | 0.070 |
Why?
|
Catalase | 1 | 2006 | 222 | 0.070 |
Why?
|
Viral Hepatitis Vaccines | 2 | 1997 | 80 | 0.070 |
Why?
|
Male | 20 | 2020 | 350118 | 0.070 |
Why?
|
Hypersensitivity, Delayed | 4 | 2011 | 484 | 0.070 |
Why?
|
Hepatitis A | 2 | 1997 | 133 | 0.070 |
Why?
|
Hematopoiesis | 1 | 2015 | 2072 | 0.070 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2005 | 57 | 0.070 |
Why?
|
Guinea Pigs | 3 | 1997 | 1386 | 0.070 |
Why?
|
Phagocytosis | 1 | 2011 | 1539 | 0.070 |
Why?
|
Granulocytes | 1 | 1987 | 548 | 0.070 |
Why?
|
Granuloma | 1 | 1987 | 319 | 0.060 |
Why?
|
Pregnancy | 3 | 2020 | 29144 | 0.060 |
Why?
|
Catalysis | 1 | 2006 | 761 | 0.060 |
Why?
|
Lung Diseases | 1 | 2015 | 1886 | 0.060 |
Why?
|
Antibodies | 2 | 2003 | 2460 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1564 | 0.060 |
Why?
|
Immunity | 1 | 1990 | 1012 | 0.060 |
Why?
|
Humans | 32 | 2020 | 744343 | 0.060 |
Why?
|
Signal Transduction | 5 | 2011 | 23403 | 0.060 |
Why?
|
Free Radicals | 3 | 1989 | 237 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 597 | 0.060 |
Why?
|
Graft vs Host Reaction | 1 | 2003 | 104 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2014 | 2149 | 0.060 |
Why?
|
Lymphocytes | 1 | 2011 | 2617 | 0.060 |
Why?
|
Antigens, Surface | 1 | 1987 | 1663 | 0.050 |
Why?
|
Phosphorylation | 2 | 2011 | 8436 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2035 | 0.050 |
Why?
|
Maternal Behavior | 1 | 2005 | 311 | 0.050 |
Why?
|
Macrophages | 2 | 1988 | 5655 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1839 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2006 | 1369 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2011 | 11483 | 0.050 |
Why?
|
Spleen | 3 | 2011 | 2362 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3386 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2001 | 517 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2002 | 273 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6622 | 0.050 |
Why?
|
Cornea | 3 | 2004 | 1524 | 0.050 |
Why?
|
Freund's Adjuvant | 1 | 2001 | 139 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4420 | 0.050 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 449 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2007 | 4328 | 0.050 |
Why?
|
Monocytes | 3 | 1994 | 2596 | 0.050 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 1038 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2010 | 3420 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 645 | 0.040 |
Why?
|
Mice, Inbred DBA | 3 | 2011 | 642 | 0.040 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 113 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2003 | 853 | 0.040 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 492 | 0.040 |
Why?
|
Blood Cells | 1 | 2002 | 309 | 0.040 |
Why?
|
Minor Histocompatibility Loci | 1 | 1999 | 18 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3798 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 2957 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1821 | 0.040 |
Why?
|
Primates | 2 | 2015 | 545 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2203 | 0.040 |
Why?
|
Cancer Vaccines | 1 | 2006 | 1023 | 0.040 |
Why?
|
Histocompatibility Testing | 2 | 2015 | 741 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 1988 | 0.040 |
Why?
|
Kinetics | 2 | 1999 | 6473 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6314 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 1999 | 414 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2006 | 1889 | 0.040 |
Why?
|
Mutation | 2 | 2006 | 29786 | 0.040 |
Why?
|
Bone Marrow | 1 | 1987 | 2948 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2000 | 2050 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2085 | 0.030 |
Why?
|
Membrane Glycoproteins | 3 | 2004 | 3768 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 1988 | 906 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2001 | 1000 | 0.030 |
Why?
|
Psychiatric Nursing | 1 | 1995 | 17 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2001 | 3474 | 0.030 |
Why?
|
Lymphokines | 1 | 1998 | 949 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5535 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4320 | 0.030 |
Why?
|
Cross Reactions | 1 | 1996 | 841 | 0.030 |
Why?
|
Horses | 1 | 2015 | 304 | 0.030 |
Why?
|
Receptors, IgG | 2 | 1987 | 582 | 0.030 |
Why?
|
Cell Transplantation | 1 | 1995 | 477 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 224 | 0.030 |
Why?
|
Ligands | 1 | 2001 | 3282 | 0.030 |
Why?
|
Professional Misconduct | 1 | 1994 | 73 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 1991 | 1423 | 0.030 |
Why?
|
Scientific Misconduct | 1 | 1994 | 71 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1678 | 0.030 |
Why?
|
Genes, MHC Class II | 1 | 1994 | 457 | 0.030 |
Why?
|
Protein Binding | 2 | 2014 | 9386 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 708 | 0.030 |
Why?
|
Inflammation | 2 | 2015 | 10638 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1991 | 821 | 0.030 |
Why?
|
Blood | 1 | 1994 | 598 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 72290 | 0.020 |
Why?
|
Blood Group Incompatibility | 1 | 2011 | 146 | 0.020 |
Why?
|
Superoxides | 1 | 1991 | 387 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2124 | 0.020 |
Why?
|
Cell Division | 2 | 2002 | 4568 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 1989 | 104 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13695 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 411 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 4803 | 0.020 |
Why?
|
Rats | 2 | 2006 | 24260 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1991 | 548 | 0.020 |
Why?
|
Rosette Formation | 1 | 1987 | 153 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10943 | 0.020 |
Why?
|
Biopsy | 2 | 2012 | 6756 | 0.020 |
Why?
|
Mice, SCID | 2 | 2004 | 2716 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4740 | 0.020 |
Why?
|
Acrylic Resins | 1 | 1987 | 142 | 0.020 |
Why?
|
Immunoglobulin Isotypes | 1 | 1987 | 158 | 0.020 |
Why?
|
Lectins | 1 | 1989 | 513 | 0.020 |
Why?
|
Pilot Projects | 2 | 2015 | 8324 | 0.020 |
Why?
|
Cell Line | 4 | 2014 | 15997 | 0.020 |
Why?
|
Gamma Rays | 1 | 1988 | 320 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7149 | 0.020 |
Why?
|
Time Factors | 3 | 2004 | 40075 | 0.020 |
Why?
|
HIV | 1 | 1994 | 1604 | 0.020 |
Why?
|
Gammaproteobacteria | 1 | 2006 | 29 | 0.020 |
Why?
|
Base Sequence | 2 | 2014 | 12797 | 0.020 |
Why?
|
Isotopes | 1 | 2006 | 124 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6773 | 0.020 |
Why?
|
Vaccines, Inactivated | 2 | 1997 | 184 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1997 | 3176 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2006 | 322 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2006 | 157 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2006 | 311 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2232 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6489 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1352 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1676 | 0.010 |
Why?
|
Clonal Anergy | 1 | 2004 | 169 | 0.010 |
Why?
|
Kidney | 2 | 2011 | 7186 | 0.010 |
Why?
|
Antigens, CD | 2 | 2004 | 4026 | 0.010 |
Why?
|
Busulfan | 1 | 2003 | 263 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2003 | 1420 | 0.010 |
Why?
|
Immune Sera | 1 | 2001 | 641 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 2001 | 253 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2000 | 96 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3494 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1987 | 1869 | 0.010 |
Why?
|
Point Mutation | 1 | 2006 | 1623 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 1200 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2000 | 199 | 0.010 |
Why?
|
Tacrolimus | 1 | 2003 | 743 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1009 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12951 | 0.010 |
Why?
|
Adipocytes | 1 | 2006 | 1184 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10481 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 927 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2003 | 2726 | 0.010 |
Why?
|
Antibody Formation | 1 | 2002 | 1402 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1706 | 0.010 |
Why?
|
Oxygen | 1 | 1989 | 4189 | 0.010 |
Why?
|
Hepatitis A Vaccines | 1 | 1997 | 29 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 2088 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 7913 | 0.010 |
Why?
|
Neoplasms | 1 | 2006 | 21683 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2429 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9856 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 1880 | 0.010 |
Why?
|
Immunogenetics | 1 | 1995 | 67 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2749 | 0.010 |
Why?
|
Consumer Product Safety | 1 | 1995 | 122 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4982 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16365 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2006 | 3479 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2006 | 12072 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18029 | 0.010 |
Why?
|
France | 1 | 1994 | 517 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2635 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11366 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2003 | 3107 | 0.010 |
Why?
|
DNA | 1 | 2006 | 7301 | 0.010 |
Why?
|
Ionomycin | 1 | 1991 | 109 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11031 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 13033 | 0.010 |
Why?
|
Trans-Activators | 1 | 2000 | 2924 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1995 | 1677 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1263 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1994 | 1155 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39050 | 0.010 |
Why?
|
Adolescent | 2 | 1995 | 85781 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1991 | 349 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1994 | 1602 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14722 | 0.000 |
Why?
|
Disulfides | 1 | 1988 | 457 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1991 | 1537 | 0.000 |
Why?
|
Molecular Weight | 1 | 1988 | 2255 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1801 | 0.000 |
Why?
|
Protein Processing, Post-Translational | 1 | 1993 | 1990 | 0.000 |
Why?
|
Binding Sites | 1 | 1993 | 6114 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 19905 | 0.000 |
Why?
|
Staphylococcus aureus | 1 | 1991 | 1451 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9648 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1994 | 5867 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29063 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2002 | 63114 | 0.000 |
Why?
|
Middle Aged | 1 | 1995 | 213383 | 0.000 |
Why?
|
Adult | 1 | 1995 | 214055 | 0.000 |
Why?
|